Watchlist Price Alert

Astellas Pharma Inc. (ALPMY)

OTC: ALPMY · Real-Time Price · USD

9.57

-0.06 (-0.62%)

At close: Jun 16, 2025, 3:58 PM

Astellas Pharma Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Revenue	1,603.7B	1,518.6B	1,296.2B	1,249.5B	1,300.8B	1,306.3B	1,300.3B	1,311.7B	1,372.7B
Cost of Revenue	292.49B	326.79B	281.29B	269.83B	297.9B	327.26B	330.09B	356.34B	377.98B
Gross Profit	1,311.2B	1,191.8B	1,014.9B	979.7B	1,002.9B	979.09B	970.23B	955.33B	994.72B
Operating Income	25.52B	285.43B	220.02B	250.9B	279.42B	280.14B	271.24B	276.42B	270.58B
Interest Income	11.46B	5.21B	794M	683M	2.16B	2.69B	1.65B	978M	985M
Pretax Income	24.97B	131.1B	156.4B	144.85B	247.01B	248.97B	218.11B	281.77B	261.77B
Net Income	17.05B	98.71B	124.09B	120.59B	195.41B	222.26B	164.68B	218.7B	193.69B
Selling & General & Admin	740.11B	630.27B	548.84B	504.32B	499.3B	490.26B	478.21B	470.78B	498.48B
Research & Development	294.2B	276.13B	246.01B	224.49B	224.23B	208.68B	220.78B	208.13B	225.66B
Other Expenses	251.36B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1,285.7B	906.4B	794.85B	728.8B	723.52B	698.95B	698.99B	678.91B	724.15B
Interest Expense	12.01B	3.62B	4.95B	2.33B	3B	1.3B	1.31B	1.33B	1.26B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1,578.2B	1,233.2B	1,076.1B	998.63B	1,021.4B	1,026.2B	1,029.1B	1,035.2B	1,102.1B
Income Tax Expense	7.92B	33.65B	32.8B	24.73B	49.94B	26.7B	53.43B	63.07B	68.08B
Shares Outstanding (Basic)	1.79B	1.82B	1.85B	1.86B	1.88B	1.93B	2.03B	2.11B	2.16B
Shares Outstanding (Diluted)	1.8B	1.83B	1.85B	1.86B	1.88B	1.93B	2.03B	2.11B	2.16B
EPS (Basic)	9.51	54.24	67.08	64.93	104.15	115.05	81.11	103.69	89.75
EPS (Diluted)	9.47	54.09	67.05	64.90	104.08	114.94	81.02	103.55	89.62
EBITDA	194.81B	246.88B	241.52B	220.31B	314.75B	313.73B	284.76B	347.54B	332.58B
EBIT	36.97B	141.14B	161.84B	147.66B	248.35B	250.27B	219.9B	283.75B	263.4B
Depreciation & Amortization	157.84B	105.74B	79.68B	72.65B	66.4B	63.46B	64.86B	63.79B	69.19B